High materiality7/10
Zimmer Biomet price target raised to $120 from $115 at UBS
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS raises ZBH target to $120; current price is $97.06; upside potential remains.
- Target $120 (from $115) by UBS; current price $97.06.
- Upside remains modest but notable.
Key facts
- 01
Target: $120
- 02
Posted price: $97.06
- 03
Analyst firm: UBS
- 04
Analyst: Patrick Wood
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.